Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Clinical trial NCT00002767 · UNKNOWN

Trial details

NCT number: NCT00002767
Sponsor: GlaxoSmithKline
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1996-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.